• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾病患者中与血压相关的血清代谢物

Serum Metabolites Associated with Blood Pressure in Chronic Kidney Disease Patients.

作者信息

Yan Fengyao, Chen Dan-Qian, Tang Jijun, Zhao Ying-Yong, Guo Yan

机构信息

Department of Computer Science, University of South Carolina, Columbia, SC 37027, USA.

Faculty of Life Science and Medicine, Northwest University, Xi'an 710127, China.

出版信息

Metabolites. 2022 Mar 23;12(4):281. doi: 10.3390/metabo12040281.

DOI:10.3390/metabo12040281
PMID:35448468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9027690/
Abstract

Blood pressure is one of the most basic health screenings and it has a complex relationship with chronic kidney disease (CKD). Controlling blood pressure for CKD patients is crucial for curbing kidney function decline and reducing the risk of cardiovascular disease. Two independent CKD cohorts, including matched controls (discovery = 824; validation = 552), were recruited. High-throughput metabolomics was conducted with the patients' serum samples using mass spectrometry. After controlling for CKD severity and other clinical hypertension risk factors, we identified ten metabolites that have significant associations with blood pressure. The quantitative importance of these metabolites was verified in a fully connected neural network model. Of the ten metabolites, seven have not previously been associated with blood pressure. The metabolites that had the strongest positive association with blood pressure were aspartylglycosamine ( = 4.58 × 10), fructose-1,6-diphosphate ( = 1.19 × 10) and N-Acetylserine ( = 3.27 × 10). Three metabolites that were negatively associated with blood pressure (phosphocreatine, = 6.39 × 10; dodecanedioic acid, = 0.01; phosphate, = 0.04) have been reported previously to have beneficial effects on hypertension. These results suggest that intake of metabolites as supplements may help to control blood pressure in CKD patients.

摘要

血压是最基本的健康筛查项目之一,它与慢性肾脏病(CKD)有着复杂的关系。控制CKD患者的血压对于抑制肾功能衰退和降低心血管疾病风险至关重要。我们招募了两个独立的CKD队列,包括匹配的对照组(发现队列 = 824人;验证队列 = 552人)。使用质谱仪对患者的血清样本进行了高通量代谢组学分析。在控制了CKD严重程度和其他临床高血压风险因素后,我们确定了十种与血压有显著关联的代谢物。这些代谢物的定量重要性在一个全连接神经网络模型中得到了验证。在这十种代谢物中,有七种以前未与血压相关联。与血压呈最强正相关的代谢物是天冬氨酰葡糖胺(= 4.58 × 10)、果糖-1,6-二磷酸(= 1.19 × 10)和N-乙酰丝氨酸(= 3.27 × 10)。三种与血压呈负相关的代谢物(磷酸肌酸,= 6.39 × 10;十二烷二酸,= 0.01;磷酸盐,= 0.04)以前曾被报道对高血压有有益作用。这些结果表明,摄入代谢物作为补充剂可能有助于控制CKD患者的血压。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78dd/9027690/4f822e4a57f9/metabolites-12-00281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78dd/9027690/821a3f89b12f/metabolites-12-00281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78dd/9027690/4f822e4a57f9/metabolites-12-00281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78dd/9027690/821a3f89b12f/metabolites-12-00281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78dd/9027690/4f822e4a57f9/metabolites-12-00281-g002.jpg

相似文献

1
Serum Metabolites Associated with Blood Pressure in Chronic Kidney Disease Patients.慢性肾病患者中与血压相关的血清代谢物
Metabolites. 2022 Mar 23;12(4):281. doi: 10.3390/metabo12040281.
2
Serum metabolites are associated with all-cause mortality in chronic kidney disease.血清代谢物与慢性肾脏病的全因死亡率相关。
Kidney Int. 2018 Aug;94(2):381-389. doi: 10.1016/j.kint.2018.03.008. Epub 2018 Jun 2.
3
Serum metabolite concentrations and decreased GFR in the general population.一般人群中血清代谢物浓度与肾小球滤过率降低。
Am J Kidney Dis. 2012 Aug;60(2):197-206. doi: 10.1053/j.ajkd.2012.01.014. Epub 2012 Mar 30.
4
Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.肾功能受损患者果糖摄入对尿酸和血浆脂质的急性影响。
Metabolism. 2013 Oct;62(10):1462-9. doi: 10.1016/j.metabol.2013.05.020. Epub 2013 Jul 15.
5
Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.代谢产物与肾功能下降和普通人群中慢性肾脏病的发生有关。
Nephrol Dial Transplant. 2013 Aug;28(8):2131-8. doi: 10.1093/ndt/gft217. Epub 2013 Jun 5.
6
MicroRNAs in the miR-17 and miR-15 families are downregulated in chronic kidney disease with hypertension.miR-17和miR-15家族中的微小RNA在伴有高血压的慢性肾病中表达下调。
PLoS One. 2017 Aug 3;12(8):e0176734. doi: 10.1371/journal.pone.0176734. eCollection 2017.
7
Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease.尿代谢物以及常见和罕见的遗传变异与慢性肾脏病的发生有关。
Kidney Int. 2017 Jun;91(6):1426-1435. doi: 10.1016/j.kint.2017.01.007. Epub 2017 Mar 14.
8
Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).11βHSD 型 2 酶活性在原发性高血压和慢性肾脏病(CKD)儿童中的作用。
J Clin Endocrinol Metab. 2012 Oct;97(10):3622-9. doi: 10.1210/jc.2012-1411. Epub 2012 Aug 7.
9
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].[慢性肾脏病(CKD)患者的动脉高血压和血脂异常。抗血小板聚集。目标导向治疗]
Nefrologia. 2008;28 Suppl 3:39-48.
10
Altered dietary salt intake for people with chronic kidney disease.慢性肾病患者饮食中盐摄入量的改变
Cochrane Database Syst Rev. 2015 Feb 18(2):CD010070. doi: 10.1002/14651858.CD010070.pub2.

引用本文的文献

1
Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study.探索1400种血浆代谢物与多囊卵巢综合征:一项双向孟德尔随机化研究
Brain Behav. 2025 Aug;15(8):e70745. doi: 10.1002/brb3.70745.
2
Chronic kidney disease prevalence in asymptomatic patients with risk factors-usefulness of serum cystatin C: a cross-sectional study.有风险因素的无症状患者的慢性肾脏病患病率——血清胱抑素C的作用:一项横断面研究
Porto Biomed J. 2023 Dec 13;8(6):e233. doi: 10.1097/j.pbj.0000000000000233. eCollection 2023 Nov-Dec.
3
Deubiquitinase USP33 promotes the glycolysis and growth of osteosarcoma by modifying PFKFB3 ubiquitination and degradation.

本文引用的文献

1
Endothelial Spns2 and ApoM Regulation of Vascular Tone and Hypertension Via Sphingosine-1-Phosphate.内皮细胞 Spns2 和 ApoM 通过鞘氨醇-1-磷酸调节血管张力和高血压。
J Am Heart Assoc. 2021 Jul 20;10(14):e021261. doi: 10.1161/JAHA.121.021261. Epub 2021 Jul 9.
2
JF1/B6F1 Ngly1 mouse as an isogenic animal model of NGLY1 deficiency.JF1/B6F1 Ngly1 小鼠作为 NGLY1 缺乏症的同基因动物模型。
Proc Jpn Acad Ser B Phys Biol Sci. 2021;97(2):89-102. doi: 10.2183/pjab.97.005.
3
Correlation of serum N-Acetylneuraminic acid with the risk and prognosis of acute coronary syndrome: a prospective cohort study.
去泛素化酶USP33通过修饰PFKFB3的泛素化和降解来促进骨肉瘤的糖酵解和生长。
Am J Cancer Res. 2023 Mar 15;13(3):922-935. eCollection 2023.
血清 N-乙酰神经氨酸与急性冠状动脉综合征风险和预后的相关性:一项前瞻性队列研究。
BMC Cardiovasc Disord. 2020 Sep 10;20(1):404. doi: 10.1186/s12872-020-01690-z.
4
Correction to: Management of Hypertension in Chronic Kidney Disease.《慢性肾脏病高血压管理》勘误
Drugs. 2020 Sep;80(13):1381. doi: 10.1007/s40265-020-01388-8.
5
Plasma metabolites mediate the association of coarse grain intake with blood pressure in hypertension-free adults.血浆代谢物介导了粗粮摄入量与高血压人群血压之间的关联。
Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1512-1519. doi: 10.1016/j.numecd.2020.05.021. Epub 2020 Jun 2.
6
Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.肠道微生物代谢产物与血压调节:聚焦于短链脂肪酸和氧化三甲胺
Physiology (Bethesda). 2020 Jul 1;35(4):275-284. doi: 10.1152/physiol.00004.2020.
7
Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.代谢物与高血压:将高血压视为一种代谢疾病的新视角:2019 年 Harriet Dustan 奖。
Hypertension. 2020 Jun;75(6):1386-1396. doi: 10.1161/HYPERTENSIONAHA.120.13896. Epub 2020 Apr 27.
8
Protection of diabetes-induced kidney injury by phosphocreatine via the regulation of ERK/Nrf2/HO-1 signaling pathway.磷酸肌酸通过调节 ERK/Nrf2/HO-1 信号通路保护糖尿病诱导的肾脏损伤。
Life Sci. 2020 Feb 1;242:117248. doi: 10.1016/j.lfs.2019.117248. Epub 2019 Dec 31.
9
Machine learning distilled metabolite biomarkers for early stage renal injury.机器学习提取早期肾损伤的代谢物生物标志物。
Metabolomics. 2019 Dec 5;16(1):4. doi: 10.1007/s11306-019-1624-0.
10
Sphingosine-1-phosphate signaling in blood pressure regulation.鞘氨醇-1-磷酸信号在血压调节中的作用。
Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F638-F640. doi: 10.1152/ajprenal.00572.2018. Epub 2019 Aug 7.